Visa and Bridge Partner to Make Stablecoins Accessible for Everyday Purchases
Cardholders will be able to make everyday purchases from a stablecoin balance at any merchant location that accepts Visa. For example, when a customer in Colombia shops locally and uses their Bridge-enabled Visa card to pay a merchant, Bridge deducts the requisite funds from the customer's stablecoin balance and converts the balance into fiat, enabling the merchant to get paid in their local currency like any other transaction. Customers can add these cards to supporting digital wallets and pay at the 150M+ merchant locations that accept Visa.
"We're focused on integrating stablecoins into Visa's existing network and products in a frictionless and secure way," said Jack Forestell, Chief Product and Strategy Officer, Visa. "Partnering with Bridge represents a significant move in helping to make stablecoins usable in everyday life, giving consumers more choice in how they manage and spend their money."
Developers building with Bridge can now easily add stablecoin-linked Visa cards to their product offerings and manage these programmatically through Bridge in multiple countries. Behind the scenes, Bridge moves and converts stablecoins from and to those cards on behalf of developers. Bridge is working with Lead Bank as a financial institution partner.
The integration enables issuance of new card programs in multiple countries at once, starting with Argentina, Colombia, Ecuador, Mexico, Peru and Chile. The focus on Latin America aims to address the growing demand for consumers and businesses to utilize stablecoins to store value and fund everyday purchases. Availability will expand to countries in Europe, Africa and Asia in the coming months.
'This is a massive unlock for developers who can now build truly scalable issuing products for their users,' said Zach Abrams, CEO and Co-Founder, Bridge. 'Everyone already knows how to use cards for payments, and now everyone will be able to use stablecoins with just a tap of their card.'
About Visa
Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.
About Bridge, a Stripe company
Bridge is the leading platform for stablecoin orchestration, simplifying the ability for users to transact on crypto rails by abstracting away the complexities of using blockchains. Bridge builds stablecoin infrastructure that enables users to seamlessly transition between fiat currency and stablecoins, helping global businesses manage, store, and move money. Bridge was acquired by Stripe in February 2025.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
COMPASS DIVERSIFIED 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Compass Diversified Holdings
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)-- Kahn Swick & Foti, LLC ('KSF') and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until to file lead plaintiff applications in securities class action lawsuits against Compass Diversified Holdings (NYSE: CODI), if they purchased the Company's securities between March 1, 2023 and May 7, 2025, inclusive (the 'Class Period'). These actions are pending in the United States District Court for the Central District of California. What You May Do If you purchased securities of Compass and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ( or visit to learn more. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by July 8, 2025. About the Lawsuits Compass and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. On May 7, 2025, the Company issued a press release entitled "Compass Diversified Discloses Non-Reliance on Financial Statements for Fiscal 2024 Amid an Ongoing Internal Investigation into its Subsidiary, Lugano Holding, Inc.," disclosing that 'the Audit Committee of CODI's Board has concluded that the previously issued financial statements for 2024 require restatement and should no longer be relied upon' and that '[e]ffective May 7, 2025, Lugano's founder and CEO, Moti Ferder, resigned from all of his positions at Lugano and will not receive any severance compensation.' The Company further disclosed that '[t]he Audit Committee of CODI's Board of Directors promptly launched an investigation after CODI's senior leadership was made aware of concerns about how Lugano was potentially financing inventory' and that '[t]he investigation . . . is ongoing but has preliminarily identified irregularities in Lugano's non-CODI financing, accounting, and inventory practices.' On this news, the price of Compass' shares plummeted approximately 62%, from $17.25 per share on May 7, 2025, to $6.55 per share on May 8, 2025. The case is Matthews v. Compass Group Diversified Holdings, Inc., et al., No. 25-cv-981. A subsequent case, Tan v. Compass Group Diversified Holdings, Inc., et al., No. 25-cv-5777, extended the class period. About Kahn Swick & Foti, LLC KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg. To learn more about KSF, you may visit
Yahoo
2 hours ago
- Yahoo
Northern Oil and Gas, Inc.'s (NYSE:NOG) Stock Is Going Strong: Is the Market Following Fundamentals?
Northern Oil and Gas (NYSE:NOG) has had a great run on the share market with its stock up by a significant 27% over the last three months. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Particularly, we will be paying attention to Northern Oil and Gas' ROE today. Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Simply put, it is used to assess the profitability of a company in relation to its equity capital. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. The formula for ROE is: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Northern Oil and Gas is: 27% = US$648m ÷ US$2.4b (Based on the trailing twelve months to March 2025). The 'return' is the yearly profit. Another way to think of that is that for every $1 worth of equity, the company was able to earn $0.27 in profit. Check out our latest analysis for Northern Oil and Gas We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes. Firstly, we acknowledge that Northern Oil and Gas has a significantly high ROE. Second, a comparison with the average ROE reported by the industry of 13% also doesn't go unnoticed by us. So, the substantial 52% net income growth seen by Northern Oil and Gas over the past five years isn't overly surprising. We then compared Northern Oil and Gas' net income growth with the industry and we're pleased to see that the company's growth figure is higher when compared with the industry which has a growth rate of 37% in the same 5-year period. Earnings growth is a huge factor in stock valuation. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. Is Northern Oil and Gas fairly valued compared to other companies? These 3 valuation measures might help you decide. Northern Oil and Gas' three-year median payout ratio to shareholders is 17%, which is quite low. This implies that the company is retaining 83% of its profits. So it seems like the management is reinvesting profits heavily to grow its business and this reflects in its earnings growth number. Besides, Northern Oil and Gas has been paying dividends over a period of four years. This shows that the company is committed to sharing profits with its shareholders. Upon studying the latest analysts' consensus data, we found that the company's future payout ratio is expected to rise to 40% over the next three years. Accordingly, the expected increase in the payout ratio explains the expected decline in the company's ROE to 15%, over the same period. In total, we are pretty happy with Northern Oil and Gas' performance. In particular, it's great to see that the company is investing heavily into its business and along with a high rate of return, that has resulted in a sizeable growth in its earnings. Having said that, on studying current analyst estimates, we were concerned to see that while the company has grown its earnings in the past, analysts expect its earnings to shrink in the future. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
3 hours ago
- Business Wire
Haleon Breaks Ground on new £130m Global Oral Health Innovation Centre
LONDON--(BUSINESS WIRE)--This week, Haleon, a global leader in consumer health and maker of leading brands such as Sensodyne, parodontax and Polident, broke ground on its new Global Oral Health Innovation Centre in Weybridge, Surrey. This state-of-the-art facility will enhance Haleon's science capabilities, accelerate innovation, and serve as a centre of excellence for global oral health research. The groundbreaking ceremony, attended by UK Minister Baroness Jones, marks an important step in Haleon's ambition to reach one billion more consumers by 2030, by strengthening its oral health R&D capabilities to put health in more hands globally. Set to become the R&D epicentre for Haleon's oral health portfolio, the centre will be a dynamic hub for pioneering research, product innovation, commercial and supply chain excellence, and cross-functional collaboration. Equipped with the latest technology and global expertise, the centre will feature a cutting-edge digital immersive room designed to unlock value at pace through real-time collaboration with Haleon's manufacturing site in Levice. At the heart of the building, the atrium will create a vibrant hub for teamwork and co-creation, bringing leading expertise together to develop solutions that address unmet oral health needs for consumers around the world. Designed with sustainability at its core, the site has recently achieved a BREEAM® Outstanding rating, recognising its exceptional commitment to sustainability at Phase 1 in the design stage. Franck Riot, Chief R&D Officer, Haleon, said:" We are excited to break ground on our Global Oral Health Innovation Centre - a major investment reflecting our commitment to advancing science and innovation. This powerhouse for oral health research will strengthen Haleon's R&D capabilities and accelerate the development of cutting-edge solutions to meet the evolving oral health needs of consumers around the world. ' Chancellor of the Exchequer, Rachel Reeves MP, said: 'This exciting milestone is another demonstration of the strength of the UK life sciences sector, a key pillar to our Industrial Strategy. Under this government Britain is open for business, and through our Plan for Change we're delivering more investment, more jobs and more money in people's pockets.' UK Minister for Technology, Baroness Jones, said: 'Haleon is breaking ground on a new centre that will place the UK at the forefront of innovation to improve everyone's oral health - which we know is important to our wider health, and to children's development. This centre, and the substantial investment behind it, is proof that the UK's world-leading life sciences sector is the place to be to grow businesses and work on fresh ideas to transform healthcare. Leveraging these strengths will lead to the long-term economic growth that will help us deliver on our Plan for Change.' Jayant Singh, Global Category Lead, Oral Health, Haleon, said:" With oral diseases affecting nearly half the world's population, this marks an exciting step forward in our mission to put health in more hands for millions across the world. This centre will play a key role in harnessing the full potential of science and innovation across our oral health portfolio. ' About Haleon Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
